The Limited Times

Now you can see non-English news...

In the crosshairs after the failed offer on GSK, the boss of Unilever makes his mea culpa

2022-02-10T19:22:56.158Z


Criticized for his plan to buy the consumer health branch of GSK, Alan Jope takes care of his shareholders.


"I say this unequivocally, I am not satisfied with Unilever's recent value creation for its shareholders."

Almost a month after his failed attempt to buy the consumer health branch of GSK for 60 billion euros and the fall of 10% of the action in two days, Alan Jope makes his mea culpa.

Despite Unilever's record growth for ten years (+ 4.5% in 2021) driven by price increases, the share price of the owner of Skip, Omo, Axe, Ben & Jerry's and Dove shows a decline of 8% over six months.

On the occasion of the publication of its annual results on Thursday, the boss of the consumer giant clarified its strategy.

No question of taking the path of a mega-merger to accelerate its strategic shift towards health, beauty and hygiene, warns the CEO.

Unilever will accelerate well in these categories, but through organic growth or targeted portfolio adjustments.

Read also

Unilever is making its work revolution

“We have engaged in extensive discussions with our shareholders in recent…

This article is for subscribers only.

You have 67% left to discover.

Cultivating your freedom is cultivating your curiosity.

Keep reading your article for 1€ the first month

I ENJOY IT

Already subscribed?

Login

Source: lefigaro

All business articles on 2022-02-10

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.